Preclinical magnetic resonance imaging and systems biology in cancer research: Current applications and challenges

American Journal of Pathology

Volumn 182, Issue 2, 2013, Pages 312-318

  Albanese, Chris ^a,b   Rodriguez, Olga C ^a   Vanmeter, John ^a,b   Fricke, Stanley T ^a,c   Rood, Brian R ^c   Lee, Yichien ^a   Wang, Sean S ^a   Madhavan, Subha ^a   Gusev, Yuriy ^a   Petricoin III, Emanuel F ^d   Wang, Yue ^e  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^d GEORGE MASON UNIVERSITY   (United States)

^e State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; BIOLOGY; BRAIN DISEASE; CANCER GROWTH; CANCER RESEARCH; CARCINOGENESIS; CELL INVASION; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; DRUG EFFICACY; EX VIVO STUDY; HUMAN; IMAGE ANALYSIS; IN VIVO STUDY; INFORMATION SCIENCE; MEDULLOBLASTOMA; METABOLISM; MOLECULAR BIOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROSTATE DISEASE; REVIEW; TISSUE PERFUSION; ULTRASOUND;

EID: 84872739517     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.09.024     Document Type: Short Survey

References (35)

1. C. Albanese, O. Rodriguez, M.D. Johnson, and S. Fricke Models of Prostate cancer Drug Discov Today Dis Models 2 2005 7 13
2. E.M. Beauchamp, L. Ringer, G. Bulut, K.P. Sajwan, M.D. Hall, Y.C. Lee, D. Peaceman, M. Ozdemirli, O. Rodriguez, T.J. Macdonald, C. Albanese, J.A. Toretsky, and A. Uren Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway J Clin Invest 121 2011 148 160
3. S. Fricke, O. Rodriguez, J. Vanmeter, L. Dettin, M. Casimiro, C. Chien, T. Newell, K. Johnson, L. Ileva, M.D. Johnson, and C. Albanese In vivo magnetic resonance volumetric and spectroscopic analysis of mouse prostate cancer models Prostate 66 2006 708 717
4. C.B. Pollock, O. Rodriguez, P.L. Martin, C. Albanese, X. Li, L. Kopelovich, and R.I. Glazer Induction of metastatic gastric cancer by peroxisome proliferator-activated receptor delta activation PPAR Res 2010, 2010 571783
5. S. Madhavan, Y. Gusev, M. Harris, D.M. Tanenbaum, R. Gauba, K. Bhuvaneshwar, A. Shinohara, K. Rosso, L.A. Carabet, L. Song, R.B. Riggins, S. Dakshanamurthy, Y. Wang, S.W. Byers, R. Clarke, and L.M. Weiner G-DOC: a systems medicine platform for personalized oncology Neoplasia 13 2011 771 783
6. M.T. Tilli, A.R. Parrish, I. Cotarla, L.P. Jones, M.D. Johnson, and P.A. Furth Comparison of mouse mammary gland imaging techniques and applications: reflectance confocal microscopy. GFP imaging, and ultrasound BMC Cancer 8 2008 21
7. F.A. Gallagher, M.I. Kettunen, and K.M. Brindle Imaging pH with hyperpolarized 13C NMR Biomed 24 2011 1006 1015
8. K.R. Keshari, J. Kurhanewicz, R. Bok, P.E. Larson, D.B. Vigneron, and D.M. Wilson Hyperpolarized 13C dehydroascorbate as an endogenous redox sensor for in vivo metabolic imaging Proc Natl Acad Sci USA 108 2011 18606 18611
9. K.L. Zakian, S. Eberhardt, H. Hricak, A. Shukla-Dave, S. Kleinman, M. Muruganandham, K. Sircar, M.W. Kattan, V.E. Reuter, P.T. Scardino, and J.A. Koutcher Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging-initial results Radiology 229 2003 241 247
10. A.R. Padhani, G. Liu, D.M. Koh, T.L. Chenevert, H.C. Thoeny, T. Takahara, A. Dzik-Jurasz, B.D. Ross, M. Van Cauteren, D. Collins, D.A. Hammoud, G.J. Rustin, B. Taouli, and P.L. Choyke Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations Neoplasia 11 2009 102 125
11. J. JuanYin, K. Tracy, L. Zhang, J. Munasinghe, E. Shapiro, A. Koretsky, and K. Kelly Noninvasive imaging of the functional effects of anti-VEGF therapy on tumor cell extravasation and regional blood volume in an experimental brain metastasis model Clin Exp Metastasis 26 2009 403 414
12. J.H. Duyn, and A.P. Koretsky Novel frontiers in ultra-structural and molecular MRI of the brain Curr Opin Neurol 24 2011 386 393
13. M. Hori, K. Ishigame, H. Kabasawa, H. Kumagai, S. Ikenaga, N. Shiraga, S. Aoki, and T. Araki Precontrast and postcontrast susceptibility-weighted imaging in the assessment of intracranial brain neoplasms at 1.5 T Jpn J Radiol 28 2010 299 304
14. S. Verma, B. Turkbey, N. Muradyan, A. Rajesh, F. Cornud, M.A. Haider, P.L. Choyke, and M. Harisinghani Overview of dynamic contrast-enhanced MRI in prostate cancer diagnosis and management AJR Am J Roentgenol 198 2012 1277 1288
15. L.J. Esserman, D.A. Berry, M.C. Cheang, C. Yau, C.M. Perou, L. Carey, A. DeMichele, J.W. Gray, K. Conway-Dorsey, M.E. Lenburg, M.B. Buxton, S.E. Davis, L.J. van't Veer, C. Hudis, K. Chin, D. Wolf, H. Krontiras, L. Montgomery, D. Tripathy, C. Lehman, M.C. Liu, O.I. Olopade, H.S. Rugo, J.T. Carpenter, C. Livasy, L. Dressler, D. Chhieng, B. Singh, C. Mies, J. Rabban, Y.Y. Chen, D. Giri, A. Au, and N. Hylton Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657) Breast Cancer Res Treat 132 2012 1049 1062
16. N.J. Hudson, A. Reverter, and B.P. Dalrymple A differential wiring analysis of expression data correctly identifies the gene containing the causal mutation PLoS Comput Biol 5 2009 e1000382
17. A.L. Barabasi, N. Gulbahce, and J. Loscalzo Network medicine: a network-based approach to human disease Nat Rev Genet 12 2011 56 68
18. A. Reverter, N.J. Hudson, S.H. Nagaraj, M. Perez-Enciso, and B.P. Dalrymple Regulatory impact factors: unraveling the transcriptional regulation of complex traits from expression data Bioinformatics 26 2010 896 904
19. B. Zhang, H. Li, R.B. Riggins, M. Zhan, J. Xuan, Z. Zhang, E.P. Hoffman, R. Clarke, and Y. Wang Differential dependency network analysis to identify condition-specific topological changes in biological networks Bioinformatics 25 2009 526 532
20. B. Zhang, Y. Tian, L. Jin, H. Li, I.M. Shih, S. Madhavan, R. Clarke, E.P. Hoffman, J. Xuan, L. Hilakivi-Clarke, and Y. Wang DDN: A caBIG(R) analytical tool for differential network analysis Bioinformatics 27 2010 1036 1038
21. R. Clarke, H.W. Ressom, A. Wang, J. Xuan, M.C. Liu, E.A. Gehan, and Y. Wang The properties of high-dimensional data spaces: implications for exploring gene and protein expression data Nat Rev Cancer 8 2008 37 49
22. Y. Wang, D.J. Miller, and R. Clarke Approaches to working in high-dimensional data spaces: gene expression microarrays Br J Cancer 98 2008 1023 1028
23. G. Yu, H. Li, S. Ha, M. Shih Ie, R. Clarke, E.P. Hoffman, S. Madhavan, J. Xuan, and Y. Wang PUGSVM: a caBIG analytical tool for multiclass gene selection and predictive classification Bioinformatics 27 2011 736 738
24. A. Gulino, A. Arcella, and F. Giangaspero Pathological and molecular heterogeneity of medulloblastoma Curr Opin Oncol 20 2008 668 675
25. M. Kool, J. Koster, J. Bunt, N.E. Hasselt, A. Lakeman, P. van Sluis, D. Troost, N.S. Meeteren, H.N. Caron, J. Cloos, A. Mrsic, B. Ylstra, W. Grajkowska, W. Hartmann, T. Pietsch, D. Ellison, S.C. Clifford, and R. Versteeg Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features PLoS One 3 2008 e3088
26. P.A. Northcott, A. Korshunov, H. Witt, T. Hielscher, C.G. Eberhart, S. Mack, E. Bouffet, S.C. Clifford, C.E. Hawkins, P. French, J.T. Rutka, S. Pfister, and M.D. Taylor Medulloblastoma comprises four distinct molecular variants J Clin Oncol 29 2011 1408 1414
27. Y.J. Cho, A. Tsherniak, P. Tamayo, S. Santagata, A. Ligon, H. Greulich, R. Berhoukim, V. Amani, L. Goumnerova, C.G. Eberhart, C.C. Lau, J.M. Olson, R.J. Gilbertson, A. Gajjar, O. Delattre, M. Kool, K. Ligon, M. Meyerson, J.P. Mesirov, and S.L. Pomeroy Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome J Clin Oncol 29 2011 1424 1430
28. R.K. Mulhern, T.E. Merchant, A. Gajjar, W.E. Reddick, and L.E. Kun Late neurocognitive sequelae in survivors of brain tumours in childhood Lancet Oncol 5 2004 399 408
29. T. Sakamaki, M.C. Casimiro, X. Ju, A.A. Quong, S. Katiyar, M. Liu, X. Jiao, A. Li, X. Zhang, Y. Lu, C. Wang, S. Byers, R. Nicholson, T. Link, M. Shemluck, J. Yang, S.T. Fricke, P.M. Novikoff, A. Papanikolaou, A. Arnold, C. Albanese, and R. Pestell Cyclin d1 determines mitochondrial function in vivo Mol Cell Biol 26 2006 5449 5469
30. P. Sirajuddin, S. Das, L. Ringer, O. Rodriguez, A. Sivakumar, Y. Lee, A. Uren, S. Fricke, B. Rood, A. Ozcan, S.S. Wang, S. Karam, V.M. Yenugonda, P. Salinas, E.F. Petricoin 3rd, M.P. Lisanti, Y. Wang, R. Schlegel, B. Moasser, and C. Albanese Quantifying the CDK inhibitor VMY-1-103's activity and tissue levels in an in vivo tumor model by LC-MS/MS and by MRI Cell Cycle 11 2012 3801 3809
31. S.K. Hekmatyar, M. Wilson, N. Jerome, R.M. Salek, J.L. Griffin, A. Peet, and R.A. Kauppinen (1)H nuclear magnetic resonance spectroscopy characterisation of metabolic phenotypes in the medulloblastoma of the SMO transgenic mice Br J Cancer 103 2010 1297 1304
32. M. Pierobon, C. Belluco, L.A. Liotta, and E.F. Petricoin 3rd Reverse phase protein microarrays for clinical applications Methods Mol Biol 785 2012 3 12
33. M. Pierobon, A.J. Vanmeter, N. Moroni, F. Galdi, and E.F. Petricoin 3rd Reverse-phase protein microarrays Methods Mol Biol 823 2012 215 235
34. X. Liu, V. Ory, S. Chapman, H. Yuan, C. Albanese, B. Kallakury, O. Timofeeva, C. Nealon, A. Dalic, V. Simic, B. Haddad, J. Rhim, A. Dritschilo, A. Riegel, A. McBride, and R. Schlegel ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cells Am J Pathol 180 2012 590 607
35. H. Yuan, S. Myers, J. Wang, D. Zhou, J. Woo, B. Kallakury, M. Bazylewicz, Y. Carter, C. Albanese, N. Grant, A. Shad, A. Dritschilo, X. Liu, and R. Schlegel Conditionally reprogrammed cells from a patient with progressive respiratory papillomatosis identify a mutant HPV-11 genome and an effective therapy The N Engl J Med 367 2012 1220 1227